"10.1371_journal.pone.0113447","plos one","2014-11-26T00:00:00Z","Susan Graham; Siqin Ye; Min Qian; Alexandra R Sanford; Marco R Di Tullio; Ralph L Sacco; Douglas L Mann; Bruce Levin; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Arthur J Labovitz; Gregory Y H Lip; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; John L P Thompson; Shunichi Homma; for the WARCEF Investigators","Division of Cardiology, Department of Medicine, State University of New York Upstate Medical University, Buffalo, New York, United States of America; Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, New York, United States of America; Department of Neurology, University of Miami Miller School of Medicine, Miami, Florida, United States of America; Department of Medicine, Washington University, St. Louis, Missouri, United States of America; Kent Institute of Medicine and Health Sciences, University of Kent, Canterbury, United Kingdom; Division of Cardiology, Department of Medicine, Lehigh Valley Hospital, Allentown, Pennsylvania, United States of America; Section of Cardiology, Department of Medicine, San Francisco Veterans Affairs Medical Center, University of California San Francisco, San Francisco, California, United States of America; Department of Neurology, Columbia University Medical Center, New York, New York, United States of America; Department of Cardiovascular Medicine, University of South Florida, Tampa, Florida, United States of America; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom; Centro Neurológico de Tratamiento y Rehabilitación, Buenos Aires, Argentina; Department of Cardiology, Deventer Hospital, Deventer, Overijssel, The Netherlands; Department of Heart Diseases, Wroclaw Medical University, Military Hospital, Wroclaw, Lower Silesia, Poland; Department of Innovative Clinical Trials, University Medical Centre Göttingen, Göttingen, Lower Saxony, Germany","Conceived and designed the experiments: SG SY JLPT SH. Performed the experiments: SG MRD RLS DLM PMP RSF JRT JPM AJL GYHL CJE DJL PP SDA. Analyzed the data: SY MQ AS BL JLPT. Wrote the paper: SG SY JLPT SH.","Dr. Homma reports receiving payment from AGA Medical (now St. Jude Medical) for his work as a member of a data and safety monitoring board and consulting fees from Boehringer Ingelheim; Dr. Levin reports receiving consulting fees from United Healthcare; Dr. Teerlink reports receiving consulting fees from Amgen and grant support from Amgen, Cytokinetics, and Novartis on behalf of himself and from NovaCardia/Merck on behalf of himself and his institution; Dr. Graham reports owning stock in March Pharmaceuticals, Medtronic, and Pfizer; Dr. Labovitz reports receiving grant support from Boehringer Ingelheim on behalf of his institution, lecture fees from Boehringer Ingelheim, and fees for the development of educational presentations from the American College of Cardiology; Dr. Anker reports receiving consulting fees from Amgen, Bosch Healthcare, GlaxoSmithKline, Helsinn, LoneStar Heart, Novartis, Professional Dietetics, PsiOxus, Relypsa, SHL Telemedicine, and Thermo Fisher, grant support from Vifor Pharma, and lecture fees from Novartis, holding patents with Brahms AG and Charité Berlin, and receiving royalties from Imperial College; Dr. Ponikowski reports receiving consulting fees from Bayer, Boehringer Ingelheim, Coridea, Corthera, Johnson & Johnson, Pfizer, Respicardia, and Vifor Pharma, grant support from Vifor Pharma on behalf of himself and his institution, and lecture fees from Abbott, Boehringer Ingelheim, Merck Serono, Pfizer, Respicardia, Sanofi-Aventis, Servier, and Vifor Pharma; and Dr. Lip reports receiving consulting fees from Astellas, AstraZeneca, Bayer, Biotronik, Boehringer Inhelheim, Bristol-Myers Squibb, Pfizer, Merck, Portola, and Sanofi-Aventis, speakers bureau fees from Bayer, Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Sanofi-Aventis, and payment for the development of educational presentations from Bayer, Boehringer Ingelheim, and Merck. No other potential conflict of interest relevant to this article was reported. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","11","Susan Graham","SG",21,TRUE,4,14,5,4,TRUE,FALSE,TRUE,1,"21",TRUE
